Latest news with #equitymarket
Yahoo
5 hours ago
- Business
- Yahoo
Aristotle Atlantic's Focus Growth Strategy Sold Expedia Group (EXPE) Due to Higher Risk of a Recession
Aristotle Atlantic Partners, LLC, an investment advisor, released its 'Focus Growth Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market regained its strength in the second quarter, following initial volatility, with the S&P 500 Index rising 10.94%. The Bloomberg U.S. Aggregate Bond Index also surged 1.21% during the quarter. Aristotle Atlantic's Focus Growth strategy returned 17.70% gross of fees (17.67% net of fees) in the quarter, underperforming the Russell 1000 Growth Index's 17.84% total return. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second quarter 2025 investor letter, Aristotle Atlantic Focus Growth Strategy highlighted stocks such as Expedia Group, Inc. (NASDAQ:EXPE). Expedia Group, Inc. (NASDAQ:EXPE) is an online travel company with a market capitalization of $23.58 billion. The one-month return of Expedia Group, Inc. (NASDAQ:EXPE) was 9.60%, and its shares gained 39.80% of their value over the last 52 weeks. On July 21, 2025, Expedia Group, Inc. (NASDAQ:EXPE) stock closed at $185.47 per share. Aristotle Atlantic Focus Growth Strategy stated the following regarding Expedia Group, Inc. (NASDAQ:EXPE) in its second quarter 2025 investor letter: We sold Expedia Group due to a higher risk of a recession following the significant increase in global tariffs, which can be expected to reduce overall levels of economic activity. In addition, the negative impact on the wealth effect due to potentially declining equity markets will likely impact demand for retail travel. Travel is among the most discretionary spend categories within the consumer discretionary sector. A busy airport terminal with a family eagerly waiting for their business trip. Expedia Group, Inc. (NASDAQ:EXPE) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 54 hedge fund portfolios held Expedia Group, Inc. (NASDAQ:EXPE) at the end of the first quarter, which was 72 in the previous quarter. In the first quarter of 2025, Expedia Group, Inc. (NASDAQ:EXPE) reported revenue of $3 billion, up 3% year-over-year. While we acknowledge the potential of Expedia Group, Inc. (NASDAQ:EXPE) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Expedia Group, Inc. (NASDAQ:EXPE) and shared the list of best magic formula stocks to invest in. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Business
- Yahoo
Aristotle Atlantic's Focus Growth Acquired HubSpot (HUBS) Backed by Multiple Catalysts
Aristotle Atlantic Partners, LLC, an investment advisor, released its 'Focus Growth Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market regained its strength in the second quarter, following initial volatility, with the S&P 500 Index rising 10.94%. The Bloomberg U.S. Aggregate Bond Index also surged 1.21% during the quarter. Aristotle Atlantic's Focus Growth strategy returned 17.70% gross of fees (17.67% net of fees) in the quarter, underperforming the Russell 1000 Growth Index's 17.84% total return. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second quarter 2025 investor letter, Aristotle Atlantic Focus Growth Strategy highlighted stocks such as HubSpot, Inc. (NYSE:HUBS). HubSpot, Inc. (NYSE:HUBS) offers a cloud-based customer relationship management (CRM) platform for businesses. The one-month return of HubSpot, Inc. (NYSE:HUBS) was -1.92%, and its shares gained 11.91% of their value over the last 52 weeks. On July 21, 2025, HubSpot, Inc. (NYSE:HUBS) stock closed at $546.64 per share, with a market capitalization of $28.828 billion. Aristotle Atlantic Focus Growth Strategy stated the following regarding HubSpot, Inc. (NYSE:HUBS) in its second quarter 2025 investor letter: "HubSpot, Inc. (NYSE:HUBS) provides a cloud-based customer relationship management (CRM) platform that integrates marketing, sales, service, content management and operations hubs into a unified system. Its platform features applications and tools for tasks such as website creation, business blogging, search engine optimization, web analytics, lead generation and more, while also offering a native payment solution. Designed to create adaptable and cohesive customer experiences, HubSpot's Smart CRM and engagement hubs facilitate unified customer profiles and seamless interaction across the customer lifecycle. The hubs, available in free and paid tiers, can function independently, integrate with HubSpot's Smart platform or third-party CRMs, and scale alongside growing businesses. A team of software developers gathered around a monitor discussing a new CRM platform. HubSpot, Inc. (NYSE:HUBS) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 61 hedge fund portfolios held HubSpot, Inc. (NYSE:HUBS) at the end of the first quarter, which was 73 in the previous quarter. While we acknowledge the potential of HubSpot, Inc. (NYSE:HUBS) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered HubSpot, Inc. (NYSE:HUBS) and shared best debt-free stocks to invest in. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
6 hours ago
- Business
- Yahoo
Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results
Aristotle Atlantic Partners, LLC, an investment advisor, released its 'Focus Growth Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market regained its strength in the second quarter, following initial volatility, with the S&P 500 Index rising 10.94%. The Bloomberg U.S. Aggregate Bond Index also surged 1.21% during the quarter. Aristotle Atlantic's Focus Growth strategy returned 17.70% gross of fees (17.67% net of fees) in the quarter, underperforming the Russell 1000 Growth Index's 17.84% total return. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second quarter 2025 investor letter, Aristotle Atlantic Focus Growth Strategy highlighted stocks such as Adaptive Biotechnologies Corporation (NASDAQ:ADPT). Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is a commercial-stage biotechnology company. The one-month return of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) was -3.19%, and its shares gained 145.48% of their value over the last 52 weeks. On July 21, 2025, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) stock closed at $10.31 per share, with a market capitalization of $1.566 billion. Aristotle Atlantic Focus Growth Strategy stated the following regarding Adaptive Biotechnologies Corporation (NASDAQ:ADPT) in its second quarter 2025 investor letter: "Adaptive Biotechnologies Corporation (NASDAQ:ADPT) contributed to relative performance in the second quarter following a better-than-expected first quarter earnings report, which showed solid across-the-board momentum in both clinical testing and biopharma testing volumes. Adaptive continues to make progress on growing average selling prices (ASPs) and reducing cash burn. Adaptive is also rolling out its test on electronic medical record platforms, which will simplify the workflow and increase test ordering, processing and reporting efficiency." A doctor presenting a new diagnostic test to a patient in an exam room. Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 27 hedge fund portfolios held Adaptive Biotechnologies Corporation (NASDAQ:ADPT) at the end of the first quarter, which was 27 in the previous quarter. While we acknowledge the potential of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Adaptive Biotechnologies Corporation (NASDAQ:ADPT) and shared the list of worst aggressive growth stocks to buy according to short sellers. The fund shared in its Q1 2024, letter that Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) strategic decision coupled with strong revenue growth and profitability targets, highlights its long-term potential. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Business
- Yahoo
Here's Why Visa (V) Declined in Q2
Aristotle Atlantic Partners, LLC, an investment advisor, released its 'Focus Growth Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market regained its strength in the second quarter, following initial volatility, with the S&P 500 Index rising 10.94%. The Bloomberg U.S. Aggregate Bond Index also surged 1.21% during the quarter. Aristotle Atlantic's Focus Growth strategy returned 17.70% gross of fees (17.67% net of fees) in the quarter, underperforming the Russell 1000 Growth Index's 17.84% total return. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second quarter 2025 investor letter, Aristotle Atlantic Focus Growth Strategy highlighted stocks such as Visa Inc. (NYSE:V). Headquartered in San Francisco, California, Visa Inc. (NYSE:V) is a payment technology company. The one-month return of Visa Inc. (NYSE:V) was 0.20%, and its shares gained 32.54% of their value over the last 52 weeks. On July 21, 2025, Visa Inc. (NYSE:V) closed at $350.94 per share, with a market capitalization of $685.561 billion. Aristotle Atlantic Focus Growth Strategy stated the following regarding Visa Inc. (NYSE:V) in its second quarter 2025 investor letter: "Visa Inc. (NYSE:V) detracted from relative performance in the second quarter due to growing concerns that stablecoins could pose a long-term threat to the company's payments business. While consumer adoption of stablecoins remains limited at present, pending U.S. legislation viewed as favorable to the cryptocurrency ecosystem, along with interest from large merchants exploring the issuance of proprietary stablecoins, has highlighted potential disruption risks to parts of Visa's core network." A close-up of a credit card being swiped on a payment terminal, reflecting the company's payments technology. Visa Inc. (NYSE:V) is in 6th position on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 165 hedge fund portfolios held Visa Inc. (NYSE:V) at the end of the first quarter, which was 181 in the previous quarter. In Q1 2025, Visa Inc. (NYSE:V) reported $9.5 billion in net revenue, up 10% year-over-year. While we acknowledge the potential of Visa Inc. (NYSE:V) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Visa Inc. (NYSE:V) and shared the list of best US stocks to buy according to billionaires. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
6 hours ago
- Business
- Yahoo
Investor Confidence in Continued Growth Boosted Netflix (NFLX) in Q2
Aristotle Atlantic Partners, LLC, an investment advisor, released its 'Focus Growth Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market regained its strength in the second quarter, following initial volatility, with the S&P 500 Index rising 10.94%. The Bloomberg U.S. Aggregate Bond Index also surged 1.21% during the quarter. Aristotle Atlantic's Focus Growth strategy returned 17.70% gross of fees (17.67% net of fees) in the quarter, underperforming the Russell 1000 Growth Index's 17.84% total return. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second quarter 2025 investor letter, Aristotle Atlantic Focus Growth Strategy highlighted stocks such as Netflix, Inc. (NASDAQ:NFLX). Incorporated in 1997, Netflix, Inc. (NASDAQ:NFLX) is a streaming platform. The one-month return of Netflix, Inc. (NASDAQ:NFLX) was -3.58%, and its shares gained 91.87% of their value over the last 52 weeks. On July 21, 2025, Netflix, Inc. (NASDAQ:NFLX) stock closed at $1,233.27 per share, with a market capitalization of $524.049 billion. Aristotle Atlantic Focus Growth Strategy stated the following regarding Netflix, Inc. (NASDAQ:NFLX) in its second quarter 2025 investor letter: "Netflix, Inc. (NASDAQ:NFLX) contributed to relative performance in the second quarter, primarily due to first quarter earnings results that supported investor confidence in continued growth. In particular, additional price increases in select markets, healthy subscriber momentum and progress in the nascent ad-supported subscription tier also helped drive performance. The company reiterated its full-year targets, with no signs of weakness in domestic or international markets." A home theater with family members enjoying streaming content together. Netflix, Inc. (NASDAQ:NFLX) is in 14th position on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 150 hedge fund portfolios held Netflix, Inc. (NASDAQ:NFLX) at the end of the first quarter, compared to 144 in the fourth quarter. While we acknowledge the potential of Netflix, Inc. (NASDAQ:NFLX) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Netflix, Inc. (NASDAQ:NFLX) and shared the list of stocks to buy and sell in 2025 according to top analyst calls. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
